Asha Therapeutics Appoints Kirsten Flowers to its Board of Administrators
Asha Therapeutics (Asha), a neuro-centric biotechnology firm specializing in creating novel therapeutics for neurological ailments with excessive unmet medical want utilizing its disruptive PRISM™ expertise, at this time introduced the appointment of Kirsten Flowers to its Board of Administrators. Asha’s PRISM™ expertise has resulted in a pipeline of belongings that treats neurological illness by contemplating … [Read more…]